Top Markets
Coin of the day
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Classement en actions #40876
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Prix de l'action
$0.0127
Dernière synchronisation: 2026-08-12
Capitalisation boursière
$66.48K
Changement (1 jour)
-2.31%
Changement (1 an)
-67.44%
Pays
US
Échange Vincerx Pharma, Inc. (VINC)

Catégorie

Le prix VINC avec la capitalisation boursière de B
Vincerx Pharma, Inc. Vincerx Pharma, Inc.
VINC
$0.0127
Capitalisation boursière de Vincerx Pharma, Inc.(VINC)
Capitalisation boursière: $66.48K
En August 2026, Vincerx Pharma, Inc. a une capitalisation boursière de $66.48K. Cela fait de Vincerx Pharma, Inc. la 40876th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Vincerx Pharma, Inc. du 2020 au 2026
VINC par rapport au top 5 des plus populaires stocks
Prix pour VINC L’actif B La capitalisation boursière de B Résultats
Vincerx Pharma, Inc. Vincerx Pharma, Inc.
$1,039,732 $66.48K
$5.442T +8,186,863,466.93%
Vincerx Pharma, Inc. Vincerx Pharma, Inc.
$851,063 $66.48K
$4.455T +6,701,279,658.96%
Vincerx Pharma, Inc. Vincerx Pharma, Inc.
$797,027 $66.48K
$4.172T +6,275,800,725.61%
Vincerx Pharma, Inc. Vincerx Pharma, Inc.
$701,733 $66.48K
$3.673T +5,525,459,075.83%
Vincerx Pharma, Inc. Vincerx Pharma, Inc.
$546,933 $66.48K
$2.863T +4,306,562,675.83%